- Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche Holding AG Call TranscriptMar 20, 2024
- Full Year 2023 Lonza Group AG Earnings Call TranscriptJan 26, 2024S$79.97Earnings
- Lonza Group AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Lonza Group AG Capital Markets Day TranscriptOct 17, 2023
- Half Year 2023 Lonza Group AG Earnings Call TranscriptJul 21, 2023S$79.97Earnings
- Q1 2023 Lonza Group AG Qualitative Update Call TranscriptMay 10, 2023
- Full Year 2022 Lonza Group AG Earnings Call TranscriptJan 25, 2023S$79.97Earnings
- Lonza Group AG at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Lonza Group AG Earnings Call TranscriptJul 22, 2022S$79.97Earnings
- Full Year 2021 Lonza Group AG Earnings Call TranscriptJan 26, 2022S$79.97Earnings
- Lonza Group AG Capital Markets Day TranscriptOct 12, 2021
- Half Year 2021 Lonza Group AG Earnings Call TranscriptJul 23, 2021S$79.97Earnings
- Full Year 2020 Lonza Group AG Earnings Call TranscriptJan 27, 2021S$79.97Earnings
- Lonza Group AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Lonza Group AG Investor Update Call TranscriptOct 15, 2020
- Half Year 2020 Lonza Group AG Earnings Call TranscriptJul 24, 2020S$79.97Earnings
- Q1 2020 Lonza Group AG Qualitative Update Review Call TranscriptApr 17, 2020
- Full Year 2019 Lonza Group AG Earnings Call TranscriptJan 21, 2020S$79.97Earnings
- Half Year 2019 Lonza Group AG Earnings Call TranscriptJul 24, 2019S$79.97Earnings
- Lonza Group AG to Discuss the Carve-out of Lonza Specialty Ingredients Call TranscriptJun 03, 2019
- Q1 2019 Lonza Group AG Business Update Call TranscriptApr 18, 2019
Lonza Group AG Investor Update Call Transcript
Good afternoon to everybody, and thank you for joining us today. Also a warm welcome to those on the phone line.
As you already know from the invitation, we wanted to share with you today some details regarding the future of Lonza, its structure, cultural aspirations, reporting processes and also the short-term guidances. I want to be clear that today, we are not going to talk about the long-term strategy of the group. But it is our intention to respond to many comments and queries that are received from investors indicating that Lonza is a kind of black box.
We will open the black box, and hopefully, we will bring light into this business portfolio, which look quite dark for many of you.
Pierre-Alain Ruffieux will join us very soon, 1st of November, he's still under contract at Roche, which means there are obligations and restrictions. We are very happy he is here today this afternoon for introduction words, but he's not allowed according to the deal with Roche to answer to questions later on, so please don't put
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)